Cited by 757Adipokines, Inflammation, and Metabolic DiseasesPeroxisome Proliferator-Activated ReceptorsAdipose Tissue and Metabolism

A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity

Okada-Iwabu, Miki, Yamauchi, Toshimasa, Iwabu, Masato, Honma, Teruki, Hamagami, Ken-ichi, Matsuda, Koichi, Yamaguchi, Mamiko, Tanabe, Hiroaki +9 more·2013·Nature

Abstract

Adiponectin secreted from adipocytes binds to adiponectin receptors AdipoR1 and AdipoR2, and exerts antidiabetic effects via activation of AMPK and PPAR-α pathways, respectively. Levels of adiponectin in plasma are reduced in obesity, which causes insulin resistance and type 2 diabetes. Thus, orally active small molecules that bind to and activate AdipoR1 and AdipoR2 could ameliorate obesity-related diseases such as type 2 diabetes. Here we report the identification of orally active synthetic small-molecule AdipoR agonists. One of these compounds, AdipoR agonist (AdipoRon), bound to both AdipoR1 and AdipoR2 in vitro. AdipoRon showed very similar effects to adiponectin in muscle and liver, such as activation of AMPK and PPAR-α pathways, and ameliorated insulin resistance and glucose intolerance in mice fed a high-fat diet, which was completely obliterated in AdipoR1 and AdipoR2 double-knockout mice. Moreover, AdipoRon ameliorated diabetes of genetically obese rodent model db/db mice, and prolonged the shortened lifespan of db/db mice on a high-fat diet. Thus, orally active AdipoR agonists such as AdipoRon are a promising therapeutic approach for the treatment of obesity-related diseases such as type 2 diabetes.

Integrity signals

Registry

Crossref · 10.1038/nature12656

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Okada-Iwabu, M., Yamauchi, T., Iwabu, M., Honma, T., Hamagami, K.-I., Matsuda, K., Yamaguchi, M., Tanabe, H., Kimura-Someya, T., Shirouzu, M., Ogata, H., Tokuyama, K., Ueki, K., Nagano, T., Tanaka, A., Yokoyama, S., & Kadowaki, T.
Affiliations
  • The University of Tokyo (JP)
  • RIKEN (JP)
  • University of Tsukuba (JP)
Corresponding author
  • Yamauchi, Toshimasa
  • Kadowaki, Takashi
Venue
Nature
Published
2013-10-30
Volume
503
Issue
7477
Pages
493-499
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W2044386584
Cited by
757
References
43
Citations by year
2026: 48 · 2025: 52 · 2024: 72 · 2023: 54 · 2022: 60 · 2021: 64 · 2020: 62 · 2019: 55 · 2018: 51 · 2017: 62 · 2016: 66 · 2015: 57 · 2014: 47 · 2013: 3
FWCI
41.86
Type
journal article
Language
en
Open access
closed
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
Japan Society for the Promotion of Science (24790908, 24249053, 24700694, 23689048)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
adiponectin, AdipoR1, AdipoR2, AdipoRon, small molecule agonists, type 2 diabetes, obesity, insulin resistance, impaired glucose tolerance, AMPK, PPARα, high-fat diet, db/db mice, lifespan extension, oral drug delivery, adiponectin receptor agonist, drug discovery screening, chemical library screening
MeSH terms
Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Adenylate Kinase, Administration, Oral, Animals, Diabetes Mellitus, Type 2, Drug Evaluation, Preclinical, Enzyme Activation, Inflammation, Insulin Resistance, Liver, Longevity, Mitochondria, Muscles, Obesity, Piperidines, Transcription Factors, Triglycerides, Signal Transduction, Glucose Intolerance, Oxidative Stress, Muscle Fibers, Skeletal, PPAR alpha, Dyslipidemias, Mice, Adiponectin, Adipose Tissue, White, Receptors, Adiponectin, Small Molecule Libraries, Diet, High-Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review